Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Digestive SystemDRG 388-gastrointestinal-obstruction-with-mcc
    Ask Trek AI about this page

    Gastrointestinal Obstruction with MCC: Inpatient Reimbursement Overview

    DRG 388 encompasses inpatient stays for gastrointestinal obstruction when a Major Complication or Comorbidity is present; it includes obstructive processes that require higher-acuity care. This Diagnosis-Related Group matters for inpatient reimbursement because the presence of a Major Complication or Comorbidity increases resource use and impacts Centers for Medicare & Medicaid Services payment classification and hospital case-mix index.

    Customize your policy alerts

    Sign up for drg 388 policy alerts

    Get alerted when payer policies referencing 388 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 388 Overview

    DRG 388 covers inpatient admissions for gastrointestinal obstruction with at least one Major Complication or Comorbidity present. Typical clinical cases include small-bowel or large-bowel obstruction due to adhesions, hernia, malignancy, or inflammatory causes accompanied by severe physiologic derangements or significant comorbid conditions. This Diagnosis-Related Group affects resource intensity because the Major Complication or Comorbidity often necessitates more complex diagnostics, higher-acuity medical management, or operative intervention. It is important for Centers for Medicare & Medicaid Services payment determinations and hospital case-mix reimbursement.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute surgical intervention trials: randomized or prospective cohort studies comparing timing and techniques of operative management (e.g., emergent laparotomy versus minimally invasive adhesiolysis or endoscopic decompression) in adults admitted with high-grade mechanical small bowel or large bowel obstruction complicated by sepsis, ischemia, or organ dysfunction. These studies enroll patients during the index hospitalization to evaluate short-term outcomes such as rates of bowel resection, perioperative mortality, ICU days, and complication rates, helping clinicians determine optimal acute management strategies. Results are highly relevant to providers for clinical decision-making and to payers because differences in intervention timing and approach directly affect length of stay, resource utilization, and costs associated with the DRG.
    • Comparative effectiveness and care pathway research for nonoperative versus operative management: observational studies and pragmatic trials that examine selection criteria, success rates, and downstream resource use for nonoperative strategies (nasogastric decompression, bowel rest, IV fluids, and targeted antibiotics) versus surgical intervention in patients with partial obstruction or obstruction with significant comorbidity. These studies often focus on older adults and medically complex patients who are at higher risk of major complications and prolonged hospitalization, assessing readmission rates, need for delayed surgery, functional outcomes, and total episode-of-care costs. Findings inform protocols, risk stratification, and guideline development, which help hospitals and payers optimize care pathways to reduce unnecessary operations, complications, and costly prolonged stays associated with DRG 388.
    • Post-discharge outcomes, rehabilitation, and readmission reduction studies: cohort studies and intervention trials that target recovery, nutritional rehabilitation, and prevention of recurrent obstruction in survivors of an index admission with gastrointestinal obstruction complicated by major complication (for example, investigations of enhanced post-discharge follow-up, structured nutrition programs, or adhesion-prevention strategies). These trials enroll patients at discharge or early outpatient follow-up to measure functional recovery, quality of life, rates of 30- and 90-day readmission, and long-term health care utilization. This research is relevant for providers to improve continuity of care and patient recovery, and for payers because reducing readmissions and post-acute complications can substantially affect overall costs attributed to the DRG.

    Related Codes

    326-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-MCC

    Stomach, Esophageal and Duodenal Procedures with MCC: Inpatient Reimbursement Overview

    327-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITH-CC

    Stomach, Esophageal and Duodenal Procedures with CC: Inpatient Reimbursement Overview

    328-STOMACH-ESOPHAGEAL-AND-DUODENAL-PROCEDURES-WITHOUT-CC-MCC

    Stomach, Esophageal and Duodenal Procedures without CC/MCC: Inpatient Reimbursement Overview

    329-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-MCC

    Major Small and Large Bowel Procedures with MCC: Inpatient Reimbursement Overview

    330-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITH-CC

    Major Small and Large Bowel Procedures with CC: Inpatient Reimbursement Overview

    331-MAJOR-SMALL-AND-LARGE-BOWEL-PROCEDURES-WITHOUT-CC-MCC

    Major Small and Large Bowel Procedures without CC/MCC: Inpatient Reimbursement Overview

    332-RECTAL-RESECTION-WITH-MCC

    Rectal Resection with MCC: Inpatient Reimbursement Overview

    333-RECTAL-RESECTION-WITH-CC

    Rectal Resection with CC: Inpatient Reimbursement Overview

    334-RECTAL-RESECTION-WITHOUT-CC-MCC

    Rectal Resection without CC/MCC: Inpatient Reimbursement Overview

    335-PERITONEAL-ADHESIOLYSIS-WITH-MCC

    Peritoneal Adhesiolysis with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 57

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.